Related references
Note: Only part of the references are listed.Methylation, Glucuronidation, and Sulfonation of Daphnetin in Human Hepatic Preparations In Vitro: Metabolic Profiling, Pathway Comparison, and Bioactivity Analysis
Si-Cheng Liang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat
M. J. Bonifacio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
In Vitro Evaluation of the Effect of 7-Methyl Substitution on Glucuronidation of Daphnetin: Metabolic Stability, Isoform Selectivity, and Bioactivity Analysis
Si-Cheng Liang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Structural Modifications at the C-4 Position Strongly Affect the Glucuronidation of 6,7-Dihydroxycoumarins
Yang-Liu Xia et al.
DRUG METABOLISM AND DISPOSITION (2015)
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
Zhiguo Ma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Identification and Characterization of Human UDP-glucuronosyltransferases Responsible for the Glucuronidation of Fraxetin
Yang-Liu Xia et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
New insights for the risk of bisphenol A: Inhibition of UDP-glucuronosyltransferases (UGTs)
Hua-Mao Jiang et al.
CHEMOSPHERE (2013)
Molecular Recognition at the Active Site of Catechol-O-methyltransferase (COMT): Adenine Replacements in Bisubstrate Inhibitors
Manuel Ellermann et al.
CHEMISTRY-A EUROPEAN JOURNAL (2011)
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
M. E. Riveiro et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Identification and Characterization of Human UDP-Glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Daphnetin
Si-Cheng Liang et al.
DRUG METABOLISM AND DISPOSITION (2010)
Application and potential of capillary electroseparation methods to determine antioxidant phenolic compounds from plant food material
Elena Hurtado-Fernandez et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor
Eiichi Tsuji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Structure and Pharmacological Functions of Coumarins and Their Derivatives
L. Wu et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Characterization of human cytochrome P450 isoforms involved in the metabolism of 7-epi-paclitaxel
Y. -Y. Zhang et al.
XENOBIOTICA (2009)
Evolution and current status of research in phenolic compounds
Alain-Michel Boudet
PHYTOCHEMISTRY (2007)
Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites:: Structure-activity relationship and molecular-modeling studies
D Chen et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol O-methyltransferase:: Structure-conjugation relationships and predictive models
J Taskinen et al.
DRUG METABOLISM AND DISPOSITION (2003)
In vitro metabolism of tolcapone to reactive intermediates: Relevance to tolcapone liver toxicity
KS Smith et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold
JL Martin et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2002)
Entacapone-induced hepatotoxicity and hepatic dysfunction
A Fisher et al.
MOVEMENT DISORDERS (2002)
Characterization of catechol glucuronidation in rat liver
L Antonio et al.
DRUG METABOLISM AND DISPOSITION (2002)
AdoMet-dependent methylation, DNA methyltransferases and base flipping
XD Cheng et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
